The DOI matches its Crossref record; 27 of the 27 references it cites were found in a registry or an index.
Selective neutralization of prostaglandin E2 blocks inflammation, hyperalgesia, and interleukin 6 production in vivo.
Open accessAbstract
The role of prostaglandin E2 (PGE2) in the development of inflammatory symptoms and cytokine production was evaluated in vivo using a neutralizing anti-PGE2 monoclonal antibody 2B5. In carrageenan-induced paw inflammation, pretreatment of rats with 2B5 substantially prevented the development of tissue edema and hyperalgesia in affected paws. The antibody was shown to bind the majority of PGE2 produced at the inflammatory site. In adjuvant-induced arthritis, the therapeutic administration of 2B5 to arthritic rats substantially reversed edema in affected paws. Anti-PGE2 treatment also reduced paw levels of IL-6 RNA and serum IL-6 protein without modifying tumor necrosis factor RNA levels in the same tissue. In each model, the antiinflammatory efficacy of 2B5 was indistinguishable from that of the nonsteroidal antiinflammatory drug indomethacin, which blocked the production of all PGs. These results indicate that PGE2 plays a major role in tissue edema, hyperalgesia, and IL-6 production at sites of inflammation, and they suggest that selective pharmacologic modulation of PGE2 synthesis or activity may provide a useful means of mitigating the symptoms of inflammatory disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Nitric oxide: physiology, pathophysiology, and pharmacology.
Moncada, S., Palmer, R. M., & Higgs, E. A. (1991) · Pharmacological Reviews · doi:10.1016/s0031-6997(25)06663-3 · Cited by 15,525
Carrageenin-Induced Edema in Hind Paw of the Rat as an Assay for Antiinflammatory Drugs
Winter, C. A., Risley, E. A., & Nuss, G. W. (1962) · Experimental Biology and Medicine · doi:10.3181/00379727-111-27849 · Cited by 5,688
A new and sensitive method for measuring thermal nociception in cutaneous hyperalgesia
Hargreaves, K., Dubner, R., Brown, F., Flores, C., & Joris, J. (1988) · Pain · doi:10.1016/0304-3959(88)90026-7 · Cited by 5,135
Needleman, P., Truk, J., Jakschik, B. A., Morrison, A. R., & Lefkowith, J. B. (1986) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.55.070186.000441 · Cited by 1,807
Coleman, R. A., Smith, W. L., & Narumiya, S. (1994) · Pharmacological Reviews · doi:10.1016/s0031-6997(25)06784-5 · Cited by 1,735
Seibert, K., Zhang, Y., Leahy, K., Hauser, S., Masferrer, J., Perkins, W., Lee, L., & Isakson, P. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.25.12013 · Cited by 1,551
Self-citationSelective inhibition of inducible cyclooxygenase 2 in vivo is antiinflammatory and nonulcerogenic.
Masferrer, J. L., Zweifel, B. S., Manning, P. T., Hauser, S. D., Leahy, K. M., Smith, W. G., Isakson, P. C., & Seibert, K. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.8.3228 · Cited by 1,310
Self-citationThe eicosanoids and their biochemical mechanisms of action
Smith, W. L. (1989) · Biochemical Journal · doi:10.1042/bj2590315 · Cited by 871
Prostaglandins, Aspirin-like Drugs and Analgesia
FERREIRA, S. H. (1972) · Nature New Biology · doi:10.1038/newbio240200a0 · Cited by 866
Prostaglandin E2 regulates macrophage-derived tumor necrosis factor gene expression.
Kunkel, S. L., Spengler, M., May, M. A., Spengler, R., Larrick, J., & Remick, D. (1988) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)60727-6 · Cited by 661
Different Intracellular Locations for Prostaglandin Endoperoxide H Synthase-1 and −2
Morita, I., Schindler, M., Regier, M. K., Otto, J. C., Hori, T., DeWitt, D. L., & Smith, W. L. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.18.10902 · Cited by 572
Anderson, G. D., Hauser, S. D., McGarity, K. L., Bremer, M. E., Isakson, P. C., & Gregory, S. A. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118717 · Cited by 571
Self-citationProstaglandins as Potentiators of Increased Vascular Permeability in Inflammation
WILLIAMS, T. J., & MORLEY, J. (1973) · Nature · doi:10.1038/246215a0 · Cited by 477
The Role of Arachidonic Acid Oxygenation Products in Pain and Inflammation
Davies, P. (1984) · Annual Review of Immunology · doi:10.1146/annurev.immunol.2.1.335 · Cited by 467
Regulation of fibroblast cyclooxygenase synthesis by interleukin-1.
Raz, A., Wyche, A., Siegel, N., & Needleman, P. (1988) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)69170-7 · Cited by 398
The hyperalgesic effects of prostacyclin and prostaglandin E2
FERREIRA, S., NAKAMURA, M., & DEABREUCASTRO, M. (1978) · Prostaglandins · doi:10.1016/0090-6980(78)90199-5 · Cited by 355
Futaki, N., Yoshikawa, K., Hamasaka, Y., Arai, I., Higuchi, S., Iizuka, H., & Otomo, S. (1993) · General Pharmacology: The Vascular System · doi:10.1016/0306-3623(93)90018-s · Cited by 344
PROSTAGLANDIN E2, PROSTAGLANDIN I2 AND THE VASCULAR CHANGES OF INFLAMMATION
WILLIAMS, T. J. (1979) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1979.tb07860.x · Cited by 344
Dendorfer, U., Oettgen, P., & Libermann, T. A. (1994) · Molecular and Cellular Biology · doi:10.1128/mcb.14.7.4443 · Cited by 332
Prostaglandins, Aspirin-like Drugs and the Oedema of Inflammation
MONCADA, S., FERREIRA, S. H., & VANE, J. R. (1973) · Nature · doi:10.1038/246217a0 · Cited by 312
Goetzl, E. J., An, S., & Smith, W. L. (1995) · The FASEB Journal · doi:10.1096/fasebj.9.11.7649404 · Cited by 271
O'Sullivan, M. G., Chilton, F. H., Huggins, E. M., & McCall, C. E. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)42073-x · Cited by 208
Petersgolden, M., & Mcnish, R. W. (1993) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1993.2227 · Cited by 179
The orientation of prostaglandin endoperoxide synthases-1 and -2 in the endoplasmic reticulum.
Otto, J. C., & Smith, W. L. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)32100-2 · Cited by 130
Characterization of a monoclonal antibody that neutralizes the activity of prostaglandin E2
Mnich, S. J., Veenhuizen, A. W., Monahan, J. B., Sheehan, K. C. F., Lynch, K. R., Isakson, P. C., & Portanova, J. P. (1995) · The Journal of Immunology · doi:10.4049/jimmunol.155.9.4437 · Cited by 77
Self-citationN-Substituted dibenzoxazepines as analgesic PGE2 antagonists
Hallinan, E. A., Hagen, T. J., Husa, R. K., Tsymbalov, S., Rao, S., VANHOECK, J. ‐., Rafferty, M. F., Stapelfeld, A., Savage, M. A., & Reichman, M. (1993) · Journal of Medicinal Chemistry · doi:10.1021/jm00074a010 · Cited by 75
Antibodies which antagonise the effects of prostacyclin
Smith, J. B., Ogletree, M. L., Lefer, A. M., & Nicolaou, K. C. (1978) · Nature · doi:10.1038/274064a0 · Cited by 68
Cited by
Prostaglandins and Inflammation
Ricciotti, E., & FitzGerald, G. A. (2011) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.110.207449 · Cited by 3,803
Prostanoid Receptors: Structures, Properties, and Functions
Narumiya, S., Sugimoto, Y., & Ushikubi, F. (1999) · Physiological Reviews · doi:10.1152/physrev.1999.79.4.1193 · Cited by 2,412
Cyclooxygenase Isozymes: The Biology of Prostaglandin Synthesis and Inhibition
Simmons, D. L., Botting, R. M., & Hla, T. (2004) · Pharmacological Reviews · doi:10.1124/pr.56.3.3 · Cited by 1,693
Jakobsson, P.-J., Thorén, S., Morgenstern, R., & Samuelsson, B. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.13.7220 · Cited by 996
Wang, D. (2006) · Gut · doi:10.1136/gut.2004.047100 · Cited by 899
Metadata
- Authors
- Portanova, J. P., Zhang, Y., Anderson, G. D., Hauser, S. D., Masferrer, J. L., Seibert, K., Gregory, S. A., & Isakson, P. C.
- Venue
- The Journal of experimental medicine
- Publisher
- Rockefeller University Press
- Published
- 1996-09-01
- Volume
- 184
- Issue
- 3
- Pages
- 883-891
- ISSN
- 0022-1007 (ISSN-L)
- 1540-9538
- OpenAlex
- W2113683216
- Cited by
- 421
- References
- 27
- FWCI
- 14.09
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.